Interim analysis from the TX45 Phase 1b Part A trial demonstrated meaningful improvements in both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension ...

Primary endpoint met in Phase 2b trial with GH001 in TRD demonstrating -15.5 Point placebo-adjusted MADRS reductionFull response to the IND hold on track for submission in mid-2025Cash, cash equivalen ...

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its ...

Research and development expenses for the first quarter of 2025 increased to $9.1 million from $7.7 million for the prior ...

Asking for a Trend host Josh Lipton sits down with Roth MKM managing director and senior research analyst Rohit Kulkarni to ...

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer products in cannabis, today reported its financial and operating results ...

Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R&D Day in March, Company is on track to initiate Phase 2 ASPEN-Breast and Phase ...

Chumba is a veteran among sweepstakes casinos with one of the industry's most recognizable brands. You'll find a wide array ...

Altice USA operates under a heavy debt load, with consolidated net leverage, by our calculation, above 7.5 times EBITDA at the end of the first quarter of 2025. The firm has carri ...

Bitcoin appeared on the scene rather mysteriously in 2009, introduced in a white paper by the pseudonymous Satoshi Nakamoto (an individual or group). Bitcoin was intended to be a decentralized digital ...

T-Rex , a purpose-built blockchain for entertainment, content, and cultural virality, today announced a $17 million fundraise ...

ADMA Biologics has surged 1,314% since 2021 with soaring revenue, ASCENIV demand, and strong financials. Learn why ADMA stock ...